8-K
Current Report
ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001144204-17-028911
Material agreement · Acquisition or sale completed
- Item 1.01 Entry into a material definitive agreement
- Item 2.01 Completion of acquisition or disposition of assets
From the SEC's structured data for this filing
Loading v467631_8k.htm…